Evidence map›Paper›PMID 34689176›Full record

ArticleBone marrow transplantation2022

Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based study.

Massimo Martino, Annalisa Pitino, Mercedes Gori, Patrice Viens, Salvatore Siena, Giovanni Tripepi, Filippo Antonio Canale, Alberto Ballestrero, Claudio Zamagni, Maurizio Musso and 8 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Massimo MartinoStem Cell Transplant and Cellular Therapies, Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy. massimo.martino@ospedalerc.it.ORCID http://orcid.org/0000-0002-3987-419X
Annalisa PitinoInstitute of Clinical Physiology (IFC), Rome, Italy.
Mercedes GoriInstitute of Clinical Physiology (IFC), Rome, Italy.
Patrice ViensInstitut Paoli-Calmettes Department of Medical Oncology, Aix-Marseille Université, Inserm U1068, CNRS UMR7258, 13009, Marseille, France.
Salvatore SienaNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milano, Italy and Dipartimento di Oncologia ed Emato-Oncologia, Università degli Studi di Milano (La Statale), Milano, Italy.
Giovanni TripepiInstitute of Clinical Physiology (IFC-CNR), Research Unit of Reggio Calabria, Reggio Calabria, Italy.
Filippo Antonio CanaleStem Cell Transplant and Cellular Therapies, Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.
Alberto BallestreroDepartment of Internal Medicine, Università di Genova, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Claudio ZamagniMedical Oncology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Maurizio MussoHematology and Transplant Unit, Oncology Department La Maddalena, Palermo, Italy.
Alberto ZambelliIstituti Clinici scientifici Maugeri, Pavia, Italy.
Peter DregerDepartment Medicine V, University of Heidelberg, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-7429-8570
Manuela BadoglioEBMT Paris Study Office; Department of Haematology, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France.ORCID http://orcid.org/0000-0003-3226-2024
Simona SecondinoMedical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Giuseppe ConsoleStem Cell Transplant and Cellular Therapies, Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.
Christian ChabannonInstitut Paoli-Calmettes, Centre de Thérapie Cellulaire, Aix-Marseille Université, INSERM CBT 1409, Centre for Clinical Investigation in Biotherapy, Marseille, France.ORCID http://orcid.org/0000-0002-3755-4889
Paolo PedrazzoliMedical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
EBMT Cellular Therapy and Immunobiology Working Party (CTIWP)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsHematopoietic Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyConsolidation ChemotherapyDisease-Free SurvivalFemaleHumansRegistriesTransplantation, Autologous

Identifiers

PMID34689176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.